Publication Year

Bylsma L, Kelsh M, Jiang X, Mitchell M, Movva N, Sacks NC. To be or not to be a rare disease: An evaluation of prevalence estimates for cancers near the orphan status threshold. Poster O-008, National Organization for Rare Disorders (NORD) Rare Diseases and Orphan Products Breakthrough Summit, Washington, DC, October 25-27, 2026.

Schaefer HR, Frankenfeld CL, Wikoff D. 2026. Low- and no-calorie sweeteners lack shared target organs or modes of action required for cumulative risk assessment. Food Chem Toxicol 218(Dec):116424; doi: 10.1016/j.fct.2026.116424. PMID: 42829191. 

Suh M, Jiang X, Movva N, Pastula ST, Reichert H. The disease burden of RSV and bronchiolitis among United States infants in 2019-2023. Poster B-089, Poster Session B, International Society for Pharmacoepidemiology (ISPE) 42nd Annual Meeting, Milan, Italy, September 1, 2026.

Frankenfeld CL, Movva N, Hooda N, Gauthier J, Reichert H, Doepker C. 2026. Analysis of National Health and Nutrition Survey (NHANES): Nutrient, food, and beverage intake of glucagon-like peptide-1 receptor agonist users with type 2 diabetes, 2007-2020. J Nutr 156(8):101685; doi: 10.1016/j.tjnut.2026.101685. PMID: 42331063.

Zemrani B, Hays NP, Movva N, Reichert H, Pados B,  Saavedra JM. Parental reporting of gastrointestinal symptoms in healthy breastfed infants varies across geographies and age groups: A systematic review and meta-analysis. E-Poster EPV739/ID 3665, ESPGHAN 2026: 58^th Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Lille, France, June 24-27, 2026.

Perreault L, Rasouli N, Sanogo F, Movva N, Bylsma L, Suh M, Reichert H, Donsmark M, Girguis M, Frankenfeld C. A meta-analysis of persistence and adherence to glucagon-like peptide 1-based treatments among patients with type 2 diabetes in the United States. Abstract/Poster 1691-P, American Diabetes Association 2026 Scientific Sessions, New Orleans, LA, June 7, 2026.

Damman CJ, Frankenfeld CL. 2026. A nutrient ratio-based, web-based enabled food quality score is associated with weight and blood pressure compared with leading nutrient profiling systems. Curr Dev Nutr 10(7):109383; doi: 10.1016/j.cdnut.2026.109383. PMID: 42437199.

Nordyke RJ, Cyr P, Jensen I. Gene therapy development programs are both growing and evolving in the face of commercial headwinds. Poster Session 3/No. HPR71, ISPOR 2026, Philadelphia, PA, May 19, 2026.

Nordyke RJ, Jensen I, Hooda N, Miller B. Rising levels of innovation in expedited designations among FDA-approved drugs: 2012-2024. Poster Session 2/No. HPR63, ISPOR 2026, Philadelphia, PA, May 18, 2026.

Pokorney S, Hooda N, Jiang X, Liu Y, Sacks N, Sheikh M, Bharucha D, Desai N. Healthcare resource use and expenditures among adults with paroxysmal supraventricular tachycardia in the United States. Poster presentation, Poster Abstract 44, Academy of Managed Care Pharmacy National Meeting—AMCP 2026, Nashville, TN. J Manag Care Spec Pharm 32(4-a):S15-S16, April 13-26, 2026.